Results 201 to 210 of about 1,320,431 (321)

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

Molecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine, Sterenn Guillemot, Louis‐Bastien Weiswald, Romane Florent, Edwige Abeilard, Florence Giffard, Emilie Brotin, Mélanie Briand, Enora Dolivet, Laurent Poulain, Marie Villedieu   +10 more
wiley   +1 more source

Vivianite and Its Oxidation Products in Mammoth Ivory and Their Implications to the Burial Process

ACS Omega, 2021
Mengmeng Shen, Zhiyun Lu, Yan Xu, Xuemei He   +3 more
doaj   +1 more source

Spatio-Temporal Geographic Networks for Value Co-Creation and Technology Transfer in China with Patent Data. [PDF]

Sci Data
Su Y, Lv A, Zhi P, Chai J, Tian J.
europepmc   +1 more source

The dynamics of patent citations [PDF]

The use of patent citations as a measure of patent "quality" increased dramatically in recent years. I estimate the hazard of patent citation, and find evidence of unobserved heterogeneity.
Marco, Alan C.
core  

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

The Triad of Congenital Absence of Aortic Arch (Isthmus Aortae), Patent Ductus Arteriosus and Interventricular Septal Defect—A Trilogy

, 1959
Erich A. Everts-Suarez, Charles P. Carson   +1 more
openalex   +2 more sources

STUDIES OF THE PULMONARY AND SYSTEMIC ARTERIAL PRESSURE IN CASES OF PATENT DUCTUS ARTERIOSUS WITH SPECIAL REFERENCE TO EFFECTS OF SURGICAL CLOSURE 1 [PDF]

, 1950
Bowen E. Taylor, Albert A. Pollack, Howard B. Burchell, O. Theron Clagett, Earl H. Wood   +4 more
openalex   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Large Patent Ductus Arteriosus in an Adult With Severe Pulmonary Hypertension and Polycythemia: PDA With Severe Pulmonary Hypertension. [PDF]

JACC Case Rep
Langenfeld TL, Sati M, Bocks ML, Agarwal AK.   +3 more
europepmc   +1 more source

Embolic Occlusion of Patent Foramen Ovale [PDF]

, 1953
G. B. ELLIOTT, Robert E. Beamish
openalex   +1 more source